» Articles » PMID: 29363059

Berberine Activates Bitter Taste Responses of Enteroendocrine STC-1 Cells

Overview
Publisher Springer
Specialty Biochemistry
Date 2018 Jan 25
PMID 29363059
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Glucagon-like peptide-1 (GLP-1) is involved in the regulation of insulin secretion and glucose homeostasis. GLP-1 release is stimulated when berberine interacts with a novel G protein family (TAS2Rs) in enteroendocrine cells. In this study, we used STC-1 cells and examined a marked increase in Ca in response to various bitter compounds. Ca responses to traditional Chinese medicine extracts, including berberine, phellodendrine and coptisine, in STC-1 cells were suppressed by the phospholipase C (PLC) inhibitor U-73122, suggesting the involvement of bitter taste receptors in changing the physiological status of enteroendocrine cells in a PLC-dependent manner. STC-1 cells showed berberine-up-regulated preproglucagon (GLP-1 precursor) mRNA and GLP-1 secretion. A QPCR analysis demonstrated that TAS2R38, a subtype of the bitter taste receptor, was associated with GLP-1 secretion. Berberine-mediated GLP-1 secretion was attenuated in response to small interfering RNA silencing of TAS2R38. The current studies demonstrated that Gα-gustducin co-localized with GLP-1 and Tas2r106 in the STC-1 cells. We further utilized inhibitors of PLC and TRPM5, which are known to participate in taste signal transduction, to investigate the underlying pathways mediated in berberine-induced GLP-1 secretion. Berberine-induced GLP-1 release from enteroendocrine cells is modulated in a PLC-dependent manner through a process involving the activation of bitter taste receptors. Together, our data demonstrated a berberine-mediated GLP-1 secretion pathway in mouse enteroendocrine cells that could be of therapeutic relevance to hyperglycemia and the role of bitter taste receptors in the function of the small intestine.

Citing Articles

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation.

Movahednasab M, Dianat-Moghadam H, Khodadad S, Nedaeinia R, Safabakhsh S, Ferns G Diabetol Metab Syndr. 2025; 17(1):60.

PMID: 39962520 PMC: 11834518. DOI: 10.1186/s13098-025-01623-w.


The Remarkable Diversity of Vertebrate Bitter Taste Receptors: Recent Advances in Genomic and Functional Studies.

Itoigawa A, Nakagita T, Toda Y Int J Mol Sci. 2024; 25(23).

PMID: 39684366 PMC: 11641376. DOI: 10.3390/ijms252312654.


Biological Importance of Phellodendrine in Traditional and Modern Medicines: An Update on Therapeutic Potential in Medicine.

Patel K, Patel D Curr Drug Res Rev. 2023; 16(2):209-218.

PMID: 37488762 DOI: 10.2174/2589977515666230721153904.


Isosinensetin Stimulates Glucagon-like Peptide-1 Secretion via Activation of hTAS2R50 and the G-Mediated Signaling Pathway.

Lee S, Ko H, Jee W, Kim H, Chung W, Jang H Int J Mol Sci. 2023; 24(4).

PMID: 36835092 PMC: 9959872. DOI: 10.3390/ijms24043682.


Is Bitterness Only a Taste? The Expanding Area of Health Benefits of Brassica Vegetables and Potential for Bitter Taste Receptors to Support Health Benefits.

Zhao A, Jeffery E, Miller M Nutrients. 2022; 14(7).

PMID: 35406047 PMC: 9002472. DOI: 10.3390/nu14071434.


References
1.
Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G . Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007; 56(3):405-12. DOI: 10.1016/j.metabol.2006.10.025. View

2.
Dotson C, Zhang L, Xu H, Shin Y, Vigues S, Ott S . Bitter taste receptors influence glucose homeostasis. PLoS One. 2008; 3(12):e3974. PMC: 2597743. DOI: 10.1371/journal.pone.0003974. View

3.
Kwon H, Kwon Y, Kwon D, Lee J . Evaluation of antibacterial effects of a combination of Coptidis Rhizoma, Mume Fructus, and Schizandrae Fructus against Salmonella. Int J Food Microbiol. 2008; 127(1-2):180-3. DOI: 10.1016/j.ijfoodmicro.2008.06.020. View

4.
Singh N, Vrontakis M, Parkinson F, Chelikani P . Functional bitter taste receptors are expressed in brain cells. Biochem Biophys Res Commun. 2011; 406(1):146-51. DOI: 10.1016/j.bbrc.2011.02.016. View

5.
Chang W, Chen L, Hatch G . Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochem Cell Biol. 2015; 93(5):479-86. DOI: 10.1139/bcb-2014-0107. View